# Anesthetic Management of a Patient With Wolff-Parkinson-White Syndrome Undergoing Gynecological Robotic Surgery

**Authors:** Mohammed I Ismail, Omar R Al-Gharaibeh, Lana Talafha, Domenico Gammaldi, Giustino Varrassi, Giovanna Grasso

PMC · DOI: 10.7759/cureus.62842 · Cureus · 2024-06-21

## TL;DR

This case report describes the successful anesthetic management of a patient with Wolff-Parkinson-White syndrome undergoing robotic gynecological surgery.

## Contribution

The paper presents a detailed anesthetic protocol tailored for WPW syndrome during robotic surgery, emphasizing safety and recovery.

## Key findings

- Customized anesthetic strategies enabled safe surgery for a WPW syndrome patient.
- The patient experienced rapid recovery and early mobilization post-surgery.
- Combination anesthesia with neuromuscular monitoring minimized cardiac risks.

## Abstract

Robotic surgery provides precision and safety for minimally invasive gynecological operations but introduces unique anesthetic challenges, especially for individuals with pre-existing conditions like Wolff-Parkinson-White (WPW) syndrome. This case report addresses the anesthetic management of a 32-year-old female with WPW syndrome undergoing a myomectomy. A thorough pre-operative evaluation, including an ECG, echocardiogram, and Holter monitoring, was performed to assess the anesthetic and cardiac risks. The patient was administered a combination of loco-regional and general anesthesia, with an emphasis on neuromuscular monitoring, antiarrhythmic preparedness, and pain management to effectively manage the complexities introduced by WPW syndrome and robotic surgery. The anesthetic protocol comprised premedication with midazolam, induction using sufentanil, propofol, and rocuronium, and maintenance with desflurane, along with techniques to mitigate the effects of pneumoperitoneum and Trendelenburg positioning. Employing these strategies, the surgery concluded successfully without any anesthetic or surgical complications. The patient experienced a rapid and complete awakening, achieved optimal pain control, and was able to mobilize early, leading to her discharge 24 hours post-surgery. This case demonstrates the essential nature of customized anesthetic management for patients with WPW syndrome undergoing robotic surgery. It underscores the necessity of an exhaustive pre-operative assessment, diligent intraoperative monitoring, and active postoperative care to ensure patient safety and promote swift recovery.

## Linked entities

- **Chemicals:** midazolam (PubChem CID 4192), sufentanil (PubChem CID 41693), propofol (PubChem CID 4943), rocuronium (PubChem CID 441290), desflurane (PubChem CID 42113)
- **Diseases:** Wolff-Parkinson-White syndrome (MONDO:0008685)

## Full-text entities

- **Diseases:** WPW syndrome (MESH:D014927), pain (MESH:D010146)
- **Chemicals:** midazolam (MESH:D008874), propofol (MESH:D015742), rocuronium (MESH:D000077123), sufentanil (MESH:D017409), desflurane (MESH:D000077335)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11260423/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC11260423/full.md

---
Source: https://tomesphere.com/paper/PMC11260423